Background: Results of randomized clinical trials (RCTs) are needed to assess the efficacy of lung cancer screening with low-dose chest computed tomography (CT) in reducing lung cancer mortality. We report design and results of enrolment and baseline screening test in the ITALUNG trial, a RCT. Methods: Invitation letters were sent to subjects of 55–69 years of age clients of 269 general practitioners. Smokers or former smokers of at least 20 pack/years were eligible and after written consent were randomized in an active arm undergoing a low-dose CT annually for 4 years and in a control arm receiving no screening. Management of positive screening test was carried out using follow-up low-dose CT, fluorodeoxyglucose positron emission to...
BACKGROUND: Lung cancer has the highest mortality-rate per cancer, with an overall 5-year survival /...
A North American trial reported a significant reduction of lung cancer mortality and overall mortali...
ObjectivesLung cancer is the leading cause of death among all cancers. An estimated 29% of the globa...
Background: Results of randomized clinical trials (RCTs) are needed to assess the efficacy of lung c...
Introduction: Recruitment and nodule management are critical issues of lung cancer screening with l...
Introduction:Lung cancer screening with low dose computed tomography (CT) has not yet been evaluated...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnos...
BACKGROUND: Lung cancer screening using low-dose CT (LDCT) was shown to reduce lung cancer mortality...
Evaluation of: National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR et al. Re...
Evaluation of: National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR et al. Re...
International audienceTwo large randomized controlled trials (NLST, NELSON) revealed a significant d...
BACKGROUND: There are limited data from randomized trials regarding whether volume-based, low-dose c...
Lung cancer still has a big proportion of cancer related deaths inspite of improvements in chemother...
BACKGROUND There are limited data from randomized trials regarding whether volume-based, low-dose co...
BACKGROUND: Lung cancer has the highest mortality-rate per cancer, with an overall 5-year survival /...
A North American trial reported a significant reduction of lung cancer mortality and overall mortali...
ObjectivesLung cancer is the leading cause of death among all cancers. An estimated 29% of the globa...
Background: Results of randomized clinical trials (RCTs) are needed to assess the efficacy of lung c...
Introduction: Recruitment and nodule management are critical issues of lung cancer screening with l...
Introduction:Lung cancer screening with low dose computed tomography (CT) has not yet been evaluated...
Background: Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). E...
Lung cancer kills more people than any other cancer in the UK (5-year survival < 13%). Early diagnos...
BACKGROUND: Lung cancer screening using low-dose CT (LDCT) was shown to reduce lung cancer mortality...
Evaluation of: National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR et al. Re...
Evaluation of: National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR et al. Re...
International audienceTwo large randomized controlled trials (NLST, NELSON) revealed a significant d...
BACKGROUND: There are limited data from randomized trials regarding whether volume-based, low-dose c...
Lung cancer still has a big proportion of cancer related deaths inspite of improvements in chemother...
BACKGROUND There are limited data from randomized trials regarding whether volume-based, low-dose co...
BACKGROUND: Lung cancer has the highest mortality-rate per cancer, with an overall 5-year survival /...
A North American trial reported a significant reduction of lung cancer mortality and overall mortali...
ObjectivesLung cancer is the leading cause of death among all cancers. An estimated 29% of the globa...